Pentixapharm Ag
Clinical trials sponsored by Pentixapharm Ag, explained in plain language.
-
Promising brain cancer imaging study halted after just one patient
Diagnosis TerminatedThis study aimed to see if a special PET scan using a tracer called PentixaFor could predict how well brain lymphoma patients would respond to chemotherapy. Only one person enrolled before the study was stopped early. The goal was to see if a negative scan after a few weeks of tr…
Phase: PHASE2 • Sponsor: Pentixapharm AG • Aim: Diagnosis
Last updated May 17, 2026 13:58 UTC
-
New PET dye aims to spot lymphoma more accurately, but study halted early
Diagnosis TerminatedThis study tested a new imaging agent called [68Ga]Ga-PentixaFor to see if it could detect marginal zone lymphoma better than the standard FDG PET scan. The trial planned to include many patients but was stopped early after only 8 people enrolled. The goal was to compare how well…
Phase: PHASE3 • Sponsor: Pentixapharm AG • Aim: Diagnosis
Last updated May 13, 2026 16:03 UTC